Søgeresultater

Foreslåede emner i din søgning.
Refine Results
  1. 1
    A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 Inhibitor

    A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 Inhibitor af Anne Lynn S. Chang, Jinah Kim, Richard Luciano, Loretta Sullivan-Chang, A. Dimitrios Colevas

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance

    Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance af Liqing Wang, Rongxiang Han, Wayne W. Hancock

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)

    Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1) af Vamsidhar Velcheti, David L. Rimm, Kurt A. Schalper

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Role Played by the Programmed Death‐1–Programmed Death Ligand Pathway during Innate Immunity against<i>Mycobacterium tuberculosis</i>

    Role Played by the Programmed Death‐1–Programmed Death Ligand Pathway during Innate Immunity against<i>Mycobacterium tuberculosis</i> af Ivana B. Alvarez, Virginia Pasquinelli, Javier O. Jurado, Eduardo Abbate, Rosa Musella, Silvia de la Barrera, Verónica García

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Soluble CD80 Restores T Cell Activation and Overcomes Tumor Cell Programmed Death Ligand 1–Mediated Immune Suppression

    Soluble CD80 Restores T Cell Activation and Overcomes Tumor Cell Programmed Death Ligand 1–Mediated Immune Suppression af Samuel Haile, Sonia P. Dalal, Virginia K. Clements, Koji Tamada, Suzanne Ostrand‐Rosenberg

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    In Vivo Blockade of the Programmed Cell Death-1 Pathway Using Soluble Recombinant PD-1-Fc Enhances CD4+ and CD8+ T Cell Responses but Has Limited Clinical Benefit

    In Vivo Blockade of the Programmed Cell Death-1 Pathway Using Soluble Recombinant PD-1-Fc Enhances CD4+ and CD8+ T Cell Responses but Has Limited Clinical Benefit af Praveen K. Amancha, Jung Joo Hong, Kenneth A. Rogers, Aftab A. Ansari, François Villinger

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Induction of Painless Thyroiditis in Patients Receiving Programmed Death 1 Receptor Immunotherapy for Metastatic Malignancies

    Induction of Painless Thyroiditis in Patients Receiving Programmed Death 1 Receptor Immunotherapy for Metastatic Malignancies af Steven Orlov, Farnaz Salari, Lawrence Kashat, Paul G. Walfish

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1

    PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1 af Marguerite Ghiotto, Laurent Gauthier, N-E Serriari, Sonia Pastor, Alemseged Truneh, Jacques A. Nunès, D Olive

    Udgivet 2010
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Mycobacterium tuberculosis Promotes Regulatory T-Cell Expansion via Induction of Programmed Death-1 Ligand 1 (PD-L1, CD274) on Dendritic Cells

    Mycobacterium tuberculosis Promotes Regulatory T-Cell Expansion via Induction of Programmed Death-1 Ligand 1 (PD-L1, CD274) on Dendritic Cells af Jamma Trinath, Mohan S. Maddur, Srini V. Kaveri, Kithiganahalli Narayanaswamy Balaji, Jagadeesh Bayry

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  10. 10
    Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors

    Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors af Zuzana Čierna, Michal Mego, Věra Miškovská, Katarína Macháleková, Michal Chovanec, Daniela Světlovská, Katarina Hainova, Katarína Rejleková, Dušan Macák, S. Špánik, D Ondruš, Karol Kajo, Jozef Mardiak, Pavel Babál

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response

    The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response af Min Luo, Liwu Fu

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  12. 12
    Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma

    Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma af Joycelyn Jie Xin Lee, Alexandre Chan, Tiffany Tang

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  13. 13
    Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy

    Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy af Yuki Katsuya, Hidehito Horinouchi, Tetsuhiko Asao, Shinsuke Kitahara, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Shun‐ichi Watanabe, Koji Tsuta, Yuichiro Ohe

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages

    Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages af Thibault Vieira, Martine Antoine, Cécile Hamard, Vincent Fallet, M. Duruisseaux, Nathalie Rabbe, Anita Rodenas, Jacques Cadranel, Marie Wislez

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer

    Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer af Kazuhiko Shien, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba

    Udgivet 2016
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  16. 16
    Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)

    Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015) af Tryfon Zarganes‐Tzitzikas, Markella Konstantinidou, Yongzhi Gao, Dobrosława Krzemień, Krzysztof M. Zak, Grzegorz Dubin, Tad A. Holak, Alexander Dömlingꝉ

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  17. 17
    Development of a Companion Diagnostic for Pembrolizumab in Non–Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1

    Development of a Companion Diagnostic for Pembrolizumab in Non–Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1 af Marisa Dolled‐Filhart, Charlotte Roach, Grant Toland, Dave Stanforth, Malinka Jansson, Gregory M. Lubiniecki, Gary Ponto, Kenneth Emancipator

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer

    Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer af Sang Byung Bae, Hyun Deuk Cho, Mee‐Hye Oh, Ji Hye Lee, Si-Hyong Jang, Soon Auck Hong, Junhun Cho, Sung Yong Kim, Sun Wook Han, Jong Eun Lee, Han Jo Kim, Hyun Ju Lee

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma

    Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma af Lei Qin, Xiang Li, Amanda Stroiney, Jinrong Qu, Jeffrey Helgager, David A. Reardon, Geoffrey S. Young

    Udgivet 2017
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab

    Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab af Richard S. Barnett, Valerie S. Barta, Kenar D. Jhaveri

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:

Søgeredskaber: